Nalfurafine for severe itch in kidney dialysis patients
Part of Kidney & urinary, Skin clinical trials.
This study tests a medication called nalfurafine to see if it can reduce severe itching (pruritus) that often comes with advanced kidney disease in people on dialysis. If you have moderate to severe itching and have been on dialysis twice a week for more than 6 months, this trial may offer a potential new treatment option.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have chronic kidney disease and experience moderate to severe itching (pruritus).
- You have been on maintenance hemodialysis twice a week for more than 6 months and are stable.
- You are between 18 and 65 years old.
- You have not had phototherapy or acupuncture in the last week before starting the study.
- You do not have active cancer, active infection, certain skin conditions, or liver disease.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether hand massage can help reduce the chronic itching that many people on dialysis experience. It compares two groups to see if massage provides relief and improves quality of life.
This study tests a new oral medication, nalfurafine hydrochloride, to see if it helps reduce itching in people on dialysis. It might offer a new option for those whose current itch treatments haven't been effective.
This trial tests if a medication called nalfurafine hydrochloride (taken as a tablet that melts in your mouth) can help reduce moderate to severe itching in people receiving peritoneal dialysis for chronic kidney disease.
This trial tests if anrikefon or nalfurafine improves sleep quality in people on hemodialysis who have chronic kidney disease-related itching. It aims to find a better treatment for both itch and sleep problems.
This trial tests a drug called difelikefalin to see if it safely reduces moderate-to-severe itching in teenagers who are on hemodialysis. Itching is common in kidney disease, and this study aims to find a new treatment option.
This trial tests a drug called difelikefalin to see if it can reduce severe itching in people on hemodialysis for chronic kidney disease. If you have troublesome itching despite dialysis, this treatment might help relieve it.
Hear when a new End Stage Renal Disease on Dialysis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.